Abstract
Mitochondria are the powerhouses of cells and modulate the essential metabolic functions required for cellular survival. Various mitochondrial pathways, such as oxidative phosphorylation or production of reactive oxygen species (ROS) are dysregulated during cancer growth and development, rendering them attractive targets against cancer. Thus, the delivery of antitumor agents to mitochondria has emerged as a potential approach for treating cancer. Recent advances in nanotechnology have provided innovative solutions for overcoming the physical barriers posed by the structure of mitochondrial organelles, and have enabled the development of efficient mitochondrial nanoplatforms. In this review, we examine the importance of mitochondria during neoplastic development, explore the most recent smart designs of nano-based systems aimed at targeting mitochondria, and highlight key mitochondrial pathways in cancer cells.
Original language | English (US) |
---|---|
Article number | 103469 |
Journal | Drug Discovery Today |
Volume | 28 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2023 |
Keywords
- cancer
- drug
- mitochondria
- nanoparticles
- therapy
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery